InMed Pharmaceuticals – Introducing the BayMedica Team

Published on 24 November 2021

InMed Pharmaceuticals is a global leader in the manufacture and development of rare cannabinoids. Together with its recently acquired subsidiary, BayMedica, it has unparalleled cannabinoid manufacturing capabilities to serve a wide spectrum of consumer markets, including pharmaceutical and health and wellness.

In this video series, we’ll be introducing the BayMedica team, discussing the team members’ impressive careers, experience in the industry and what excites them about the InMed/BayMedica acquisition. Today’s video highlights Shane Johnson, SVP and General Manager of BayMedica.

Share this with friends and colleagues